J&J, GSK rheumatoid arthritis drug meets goals of large trial

(Reuters) - An experimental drug for rheumatoid arthritis developed by Johnson & Johnson and GlaxoSmithKline slowed joint damage and improved symptoms of the disease, meeting the main goals of a large, late stage trial, according to data released on Tuesday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news